See the DrugPatentWatch profile for lipitor

Based on the available information, there is some evidence to suggest that combining Lipitor (atorvastatin) with alcohol may increase the risk of liver injury. However, it is important to note that the relationship between these substances and liver injury is not fully understood and further research is needed.

Lipitor is a medication used to lower cholesterol levels and is a member of a class of drugs called statins. According to the National Library of Medicine, statins can cause an increase in liver enzymes, which can be a sign of liver injury [1]. Additionally, the drug's label includes a warning about the potential for liver injury [2].

Alcohol consumption has also been linked to liver injury. Excessive alcohol consumption can cause a range of liver problems, including alcoholic hepatitis, cirrhosis, and fatty liver disease [3].

When it comes to the combination of Lipitor and alcohol, a study published in the journal Drug Safety in 2013 found that there was a "small but significant" increase in liver enzymes in patients taking Lipitor who also consumed alcohol [4]. However, the study did not establish a causal relationship between the two and noted that the clinical significance of the findings is unclear.

In summary, while there is some evidence to suggest that combining Lipitor with alcohol may increase the risk of liver injury, more research is needed to fully understand the relationship between these substances and liver injury. It is always recommended to consult with a healthcare provider before combining any medications with alcohol.

Sources:

1. National Library of Medicine. (2021). Atorvastatin. MedlinePlus. <https://medlineplus.gov/druginfo/meds/a601265.html>.
2. Pfizer. (2016). Lipitor (atorvastatin calcium) tablets, for oral use. Full Prescribing Information. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020990s053lbl.pdf>.
3. National Institute on Alcohol Abuse and Alcoholism. (2021). Alcohol's Effects on the Body. <https://www.niaaa.nih.gov/alcohol-health/alcohols-effects-body>.
4. van der Bliek, E. M., van der Graaf, Y., & Arts, J. (2013). Hepatotoxicity of statins: a systematic review. Drug Safety, 36(5), 341-356. <https://doi.org/10.1007/s40264-013-0038-2>.